ReviewFrontiers in immunology2023

Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors.

Ying Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.